Clinical Trials
50 trialsNCT04261777 2026-04-28
Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients
Saving Patients' Lives Medical B.V.
Phase 3 Terminated
NCT04876651 2026-02-20
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3 Terminated
NCT03862170 2025-02-12
BRP30
CR-CSSS Champlain-Charles-Le Moyne
Phase 3 Terminated
NCT03031821 2024-10-04
PRIME
Canadian Urologic Oncology Group
Phase 3 Terminated
NCT03777982 2024-09-19
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Dana-Farber Cancer Institute
Phase 3 Terminated
NCT03056638 2024-08-28
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Terminated
NCT04907227 2024-07-12
KEYNOTE-921
Merck Sharp & Dohme LLC
Phase 3 Terminated
NCT04409288 2024-01-05
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer
Chinese University of Hong Kong
Phase 3 Terminated
NCT00651326 2023-08-04
DART
Canadian Cancer Trials Group
Phase 3 Terminated
NCT02438007 2023-03-15
ARMOR3-SV
LTN PHARMACEUTICALS, INC.
Phase 3 Terminated
NCT03921996 2023-03-09
Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer
Swiss Cancer Institute
Phase 3 Terminated
NCT05744115 2023-02-24
Ga68-PSMA-11
Harry S. Truman Memorial Veterans' Hospital
Phase 3 Terminated
NCT04457245 2023-01-17
PSMA-dRT
Jonsson Comprehensive Cancer Center
Phase 3 Terminated
NCT02745587 2022-12-28
PROPER
University Hospital, Ghent
Phase 3 Terminated
NCT02663908 2022-06-29
PRONOUNCE
Ferring Pharmaceuticals
Phase 3 Terminated
NCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT03532308 2021-05-26
Nutrition and Prostate Cancer
Yale University
Phase 3 Terminated
NCT02057666 2021-04-23
TasQ003
Ipsen
Phase 3 Terminated
NCT00058188 2020-12-08
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Northwestern University
Phase 3 Terminated
NCT00003645 2020-04-28
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00415246 2019-11-22
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
Ipsen
Phase 3 Terminated
NCT01313273 2019-11-22
POSEIDON
Ipsen
Phase 3 Terminated
NCT00544076 2019-01-02
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
City of Hope Medical Center
Phase 3 Terminated
NCT01522443 2018-05-23
COMET-2
Exelixis
Phase 3 Terminated
NCT00003682 2016-06-23
Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
UNICANCER
Phase 3 Terminated
NCT00216060 2016-05-26
Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
Hoosier Cancer Research Network
Phase 3 Terminated
NCT00243646 2016-04-14
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
Schiffler Cancer Center
Phase 3 Terminated
NCT00024167 2016-03-22
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00215631 2015-09-15
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
Erasmus Medical Center
Phase 3 Terminated
NCT00809458 2015-07-16
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer
New Mexico Cancer Research Alliance
Phase 3 Terminated
NCT00581113 2015-06-11
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
Virginia Commonwealth University
Phase 3 Terminated
NCT01242748 2015-06-03
A Degarelix Trial in Patients With Prostate Cancer
Ferring Pharmaceuticals
Phase 3 Terminated
NCT00949962 2014-07-04
Post-operative or Early Salvage XRT and ADT for High Risk PCa
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00831233 2013-11-11
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Ferring Pharmaceuticals
Phase 3 Terminated
NCT00005075 2013-11-06
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00514917 2013-11-04
Rising PSA
Sanofi
Phase 3 Terminated
NCT00005073 2013-05-01
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
Novartis
Phase 3 Terminated
NCT00676650 2013-03-08
SUN 1120
Pfizer
Phase 3 Terminated
NCT00014586 2012-09-24
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00626548 2012-09-03
ENTHUSE M0
AstraZeneca
Phase 3 Terminated
NCT00450970 2012-08-17
SPERA
Agennix
Phase 3 Terminated
NCT00388804 2012-08-08
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00294437 2012-05-01
ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
Central European Cooperative Oncology Group
Phase 3 Terminated
NCT00911027 2012-04-25
SonoVue Guided Prostate Biopsy
Bracco Diagnostics, Inc
Phase 3 Terminated
NCT00705822 2010-11-30
PROSTATA
Sanofi
Phase 3 Terminated
NCT00630799 2010-09-09
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
GP-Pharm
Phase 3 Terminated
NCT00391950 2009-11-23
Maintaining Bone Strength in Men With Prostate Cancer
Novartis
Phase 3 Terminated
NCT00089856 2008-11-05
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Cell Genesys
Phase 3 Terminated
NCT00133224 2008-09-23
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
Cell Genesys
Phase 3 Terminated
NCT00273338 2007-11-06
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
Novacea
Phase 3 Terminated